Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals

Yildiz Kaya, Sibel; Mete, Bilgül; Kaya, Abdurrahman; Balkan, İlker; Saltoglu, Neşe; Tabak, Ömer

doi:10.4274/vhd.52724

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals

Yildiz Kaya S., Mete B., Kaya A., Balkan I. I., Saltoglu N., Tabak F.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.23, no.1, pp.6-9, 2017 (ESCI)

Publication Type: Article / Article
Volume: 23 Issue: 1
Publication Date: 2017
Doi Number: 10.4274/vhd.52724
Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Page Numbers: pp.6-9
Istanbul University Affiliated: Yes

Abstract

Objective: Chronic hepatitis C (CHC) virus infection is one of the leading causes of chronic liver disease in all over the world. The prevalence of CHC is almost 0.5-1% in Turkey. Until recently, pegylated-interferon (PEG IFN) alpha in combination with ribavirin was the main treatment of CHC. The aim of the study was to evaluate the real life data of CHC patients.